OpenAlex topic

Vitamin K Research Studies

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 1,058 works 7 author topics

Works

1,058 works

Edoxaban versus Warfarin in Patients with Atrial Fibrillation 2013
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens…
- BAYRAM ALİ UYSAL
Edoxaban versus Warfarin in Patients with Atrial Fibrillation 2013
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%
BACKGROUND: Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. METHODS: We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens…
- MEHMET KANADAŞI
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation ROCKET AF 2014
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%
BACKGROUND: Nonvalvular atrial fibrillation is common in elderly patients, who face an elevated risk of stroke but difficulty sustaining warfarin treatment. The oral factor Xa inhibitor rivaroxaban was noninferior to warfarin in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Anta…
- BÜLENT BEHLÜL ALTUNKESER
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack a subgroup analysis of ROCKET AF 2012
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%
No abstract yet.
- BÜLENT BEHLÜL ALTUNKESER
Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers 2009
YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 98.2%
No abstract yet.
- AYŞEM KAYA
Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal Recessive Osteogenesis Imperfecta 2010
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
No abstract yet.
- FİLİZ BAKAR
Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal Recessive Osteogenesis Imperfecta 2010
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
No abstract yet.
- GÜLEN EDA ÜTİNE
Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal Recessive Osteogenesis Imperfecta 2010
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
No abstract yet.
- AYŞE NURTEN AKARSU
Disruption of ALX1 Causes Extreme Microphthalmia and Severe Facial Clefting: Expanding the Spectrum of Autosomal-Recessive ALX-Related Frontonasal Dysplasia 2010
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
No abstract yet.
- YASEMİN ALANAY
Mutations in the Gene Encoding the RER Protein FKBP65 Cause Autosomal-Recessive Osteogenesis Imperfecta 2010
YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.6%
No abstract yet.
- YASEMİN ALANAY
The Changing Landscape for Stroke Prevention in AF 2017
OpenAlex top 1% OpenAlex 99.8%
BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatra…
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF 2016
OpenAlex top 1% OpenAlex 99.5%
BACKGROUND: Atrial fibrillation is associated with higher mortality. Identification of causes of death and contemporary risk factors for all-cause mortality may guide interventions. METHODS AND RESULTS: In the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of…

Academicians

7 academicians